PDCD4 and hepatocellular carcinoma: The serum levels of programmed cell death protein 4 (PCDC4) and Cyt c were found to increase in patients with hepatocellular carcinoma (HCC) compared to chronic hepatitis patients, which were higher compared to controls (p < 0.05) [65].